title: Use of losartan in FH patients during treatment with DSC-LDL apheresis.
authors.forename: S
authors.initials: S
authors.lastname: Pintus
authors.forename: P
authors.initials: P
authors.lastname: Pintus
authors.forename: P
authors.initials: P
authors.lastname: Maxia
authors.forename: S
authors.initials: S
authors.lastname: Anedda
mesh_terms: D000804:Angiotensin II / Q000037:antagonists & inhibitors; D001781:Blood Component Removal / Q000009:adverse effects*; D016264:Dextran Sulfate; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000628:therapy*; D007022:Hypotension / Q000517:prevention & control*; D008077:Lipoproteins, LDL; D019808:Losartan / Q000627:therapeutic use*
chemical_list: D008077:Lipoproteins, LDL; D000804:Angiotensin II; D016264:Dextran Sulfate; D019808:Losartan